In line with these studies, we recently showed that activation of Nrf2 in hepatocytes afforded by genetic deletion of Keap1 was able to reduce triglycerides accumulation and ROS generation in mice subjected to experimental models of NASH [9]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.